What is the recommended dosing for Toradol (ketorolac) for pain management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Toradol (Ketorolac) Prescribing Guidelines

For adults aged 17-64 years, prescribe ketorolac 20 mg PO once as initial oral dose, followed by 10 mg every 4-6 hours as needed (maximum 40 mg/day), only as continuation therapy after IV/IM ketorolac, with total combined IV/IM and oral duration not exceeding 5 days. 1

Critical Prescribing Rule: Oral Ketorolac is NOT First-Line

  • Ketorolac tablets should never be prescribed as initial therapy - they are FDA-approved only as continuation therapy following IV or IM ketorolac administration 1
  • The oral formulation cannot be given as an initial dose in any clinical scenario 1

Standard Dosing by Patient Population

Adults Age 17-64 Years (Normal Renal Function, Weight ≥50 kg)

  • Initial oral dose: 20 mg PO once (after IV/IM ketorolac) 1
  • Maintenance: 10 mg every 4-6 hours as needed 1
  • Maximum daily dose: 40 mg/day 1
  • Do not shorten the 4-6 hour dosing interval 1

High-Risk Patients (Age ≥65 years, Renal Impairment, or Weight <50 kg)

  • Initial oral dose: 10 mg PO once (after IV/IM ketorolac) 1
  • Maintenance: 10 mg every 4-6 hours as needed 1
  • Maximum daily dose: 40 mg/day 1

Pediatric Patients (Age <17 years)

  • Oral ketorolac is not FDA-approved for children 1

Maximum Duration of Therapy

The combined duration of IV/IM and oral ketorolac must not exceed 5 days in adults 1, 2, 3. This strict time limit is essential because:

  • Risk of serious adverse events increases significantly with prolonged therapy beyond 5 days 2
  • Gastrointestinal bleeding, renal impairment, and operative site bleeding risks escalate with duration 2

Absolute Contraindications

Do not prescribe ketorolac if the patient has: 2, 3

  • History of gastrointestinal bleeding or active peptic ulcer disease
  • Current risk of gastrointestinal bleeding
  • Renal insufficiency or risk of renal failure
  • Compromised hemostasis or bleeding diathesis
  • Hypersensitivity to aspirin or other NSAIDs
  • Concurrent use of other NSAIDs (including ibuprofen, naproxen, etc.)
  • Pregnancy, labor, delivery, or breastfeeding
  • Concurrent anticoagulant therapy

Critical Drug Interaction: NSAID Stacking

Never prescribe ketorolac concurrently with other NSAIDs - this includes over-the-counter ibuprofen, naproxen, or aspirin 4, 3. The rationale:

  • Multiple NSAIDs increase gastrointestinal bleeding, renal toxicity, and cardiovascular complications without providing additional analgesic benefit 4
  • Toxicities are additive, not synergistic for analgesia 4

If Patient Recently Took Ibuprofen

  • Wait 6-8 hours after the last ibuprofen dose before administering ketorolac to allow adequate drug clearance 4
  • Ibuprofen has a 2-hour half-life with peak levels at 1-2 hours post-dose 4
  • Consider acetaminophen or opioid analgesics during the waiting period 4

High-Risk Patient Identification

Gastrointestinal Risk Factors 4, 2

  • Age ≥60 years
  • History of peptic ulcer disease
  • Significant alcohol use
  • Concurrent anticoagulant therapy

Renal Toxicity Risk Factors 4, 2

  • Age ≥60 years
  • Dehydration or compromised fluid status
  • Pre-existing renal insufficiency
  • Concurrent nephrotoxic medications

Cardiovascular Risk Factors 4

  • History of cardiovascular disease
  • Hypertension
  • Concurrent anticoagulation

Required Monitoring

Baseline Assessment 4

  • Blood pressure
  • BUN and creatinine
  • Liver function tests
  • Complete blood count
  • Fecal occult blood test

Discontinuation Criteria 4

Stop ketorolac immediately if:

  • BUN or creatinine doubles from baseline
  • Hypertension develops or worsens
  • Liver function tests increase >3 times upper limit of normal
  • Any gastrointestinal bleeding occurs

Clinical Use Recommendations

Appropriate Indications 3

  • Only prescribe for diagnosed injuries or conditions - not prophylactically for anticipated pain 3
  • Most effective for bone pain, visceral pain, and musculoskeletal injuries 5
  • Should be administered under direct physician supervision 3

Opioid-Sparing Strategy

  • Ketorolac exhibits marked opioid-sparing effects when combined with opioids 6
  • This combination improves pain relief quality and reduces opioid-related adverse effects (respiratory depression, nausea, ileus) 6
  • Consider this approach for postoperative pain management 6

Sample Prescription Format

For a 45-year-old patient (70 kg, normal renal function) after receiving IV ketorolac:

Ketorolac tromethamine 10 mg tablets
Sig: Take 20 mg (two tablets) by mouth once, then 10 mg (one tablet) every 4-6 hours as needed for pain
Disp: #30 tablets
Refills: None
Duration: Do not use for more than 5 days total (including IV/IM doses)

For a 70-year-old patient (48 kg) after receiving IV ketorolac:

Ketorolac tromethamine 10 mg tablets
Sig: Take 10 mg (one tablet) by mouth once, then 10 mg (one tablet) every 4-6 hours as needed for pain
Disp: #20 tablets
Refills: None
Duration: Do not use for more than 5 days total (including IV/IM doses)

Common Prescribing Pitfalls to Avoid

  • Never prescribe oral ketorolac as initial therapy - it requires prior IV/IM administration 1
  • Never exceed 5 days total duration (IV/IM + oral combined) 1, 2
  • Never combine with other NSAIDs - check for concurrent ibuprofen, naproxen, aspirin use 4, 3
  • Never prescribe without screening for contraindications - particularly GI bleeding history and renal function 2, 3
  • Never use prophylactically - only for diagnosed conditions 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.